Filing Details
- Accession Number:
- 0001209191-23-010936
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-17 20:22:15
- Reporting Period:
- 2023-02-15
- Accepted Time:
- 2023-02-17 20:22:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1720580 | Adicet Bio Inc. | ACET | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1643067 | Don Healey | C/O Adicet Bio, Inc. 200 Berkeley Street, 19Th Floor Boston MA 02116 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-02-15 | 4,533 | $7.57 | 66,568 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected to fund tax obligations related to PSUs and RSUs that vested in 2022 pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 11, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $7.43 to $7.72, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission staff upon request.